Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer
Dan P. Zandberg(University of Pittsburgh Medical Center), Julie E. Bauman(George Washington University), David A. Clump(West Virginia University), Gabriel Sica(Emory University), Riyue Bao(University of Pittsburgh), Brian R. Isett(UPMC Hillman Cancer Center), Raja R. Seethala(University of Pittsburgh), James Ohr(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Haiyan Li(Shihezi University), Lazar Vujanović(UPMC Hillman Cancer Center), Hong Wang(Beijing Institute of Technology), Heath D. Skinner(University of Pittsburgh)
Cited by 20
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899